Cell-free and erythrocytic S-nitrosohemoglobin inhibits human platelet aggregation

Circulation

Volumn 97, Issue 3, 1998, Pages 263-267

  Pawloski, John R ^a   Swaminathan, Rajesh V ^a   Stamler, Jonathan S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Nitric oxide; Platelets; S nitrosohemoglobin

Indexed keywords

HEMOGLOBIN DERIVATIVE; NITRIC OXIDE;

ARTICLE; BLOOD VESSEL OCCLUSION; HUMAN; HUMAN CELL; OXIDATIVE STRESS; OXYGEN TRANSPORT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 0032570313     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.3.263     Document Type: Article

References (34)

1. Azuma H, Ishikawa, M, Sekizaki S. Endothelium-dependent inhibition of platelet aggregation. Br J Pharmcol. 1986;88:411-415.
2. Furlong B, Handerson AH, Lewis MJ, Smith JA. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmcol. 1987; 90:687-692.
3. Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 1987;2: 1057-1058.
4. Mellion TB, Ignarro LJ, Ohlstein EH, Pontecorvo EG, Hyman AL, Kadowitz PJ. Evidence for the inhibitory role of guanosine 3′,5′-cyclic monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood. 1981;57:946-955.
5. Rovin JD, Stamler JS, Loscalzo J, Folts JD. Sodium nitroprusside, an endothelium-derived relaxing factor congener, increases platelet cyclic GMP levels and inhibits epinephrine-exacerbated in vivo platelet thrombus formation in stenosed canine coronary arteries. J Cardiovasc Phamacol. 1993;22:626-631.
6. Lancaster Jr. JR. Simulation of the diffusion and reaction of endogenously produced nitric oxide. Proc Natl Acad Sci U S A. 1994;91:8137-8141.
7. Makings LR, Tsien RY. Caged nitric oxide. Stable organic molecules from which nitric oxide can be photoreleased. J Biol Chem. 1994;269: 6282-6285.
8. Stamler JS. A radical vascular connection. Naiun. 1996;380:108-111.
9. Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T, Singel DJ, Loscalzo J. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci U S A. 1992;89:444-448.
10. Radomski MW, Rees DD, Dutra A, Moncada S. S-nitrosoglutathione inhibits platelet activation in vitro and in vivo. Br J Phamacol. 1992;107: 745-749.
11. Simon DI, Stamler JS, Jaraki O, Keaney JF, Osborne JA, Francis SA, Singel DJ, Loscalzo J, Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor. Arterioseler Thromb. 1993;13:791-799.
12. Meszaros LG, Minarovic I, Zahradnikova A. Inhibition of the skeletal muscle ryanodine receptor calcium release channel by nitric oxide. FEBS Lett. 1996;380:49-52.
13. Stamler JS. Redox signaling: Nitrosylation and related target interactions of nitric oxide. Cell. 1994;78:931-936.
14. Hausladen A, Privalle CT, Keng T, DeAngelo J, Stamler JS. Nitrosative stress: activation of the transcription factor oxyR. Cell. 1996;86:719-729.
15. Stamler JS, Jia L, Eu JP, McMahon TJ, Demchenko IT, Bonaventura J, Gernert K, Piantadosi CA. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science. 1997;276:2034-2037.
16. Jia L, Bonaventura C, Bonaventura J, Stamler JS. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature. 1996;380: 221-226.
17. Kharitonov VG, Bonaventura J, Sharma VS. Interactions of nitric oxide with heme proteins using UV-Vis spectroscopy. In: Feelisch M, Stamler JS. Eds. Methods in Nitric Oxide Research. West Sussex, England: John Wiley & Sons Ltd; 1996:39-47.
18. Saville B. A scheme for the colorimetric determination of microgram amounts of thiols. Analyst. 1958;83:670-672.
19. Stamler JS, Mendelsohn ME, Amarante P, Smick D, Andon N, Davies PF, Cooke JP, Loscalzo J. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res. 1989;65:789-795.
20. Santos MT, Valles J, Marcus AJ, Safier LB, Broekman MJ, Islam N, Ullman HL, Eiroa AM, Aznar J. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. J Clin Invest. 1991;87:571-580.
21. Valles J, Santos MT, Marcus AJ, Martinez-Sales V, Portoles M, Broekman MJ, Safier LB. Erythrocytes metabolically enhance platelet responsiveness via increased thromboxane production, ADP release, and recruitment. Blood. 1991;78:154-162.
22. Santos MT, Valles J, Aznar J, Marcus AJ, Broekman MJ, Safier LB. Prothrombotic effects of erythrocytes on platelet activity. Reduction by aspirin. Circulation. 1997;95:63-68.
23. Goldsmith HL, Bell DM, Braovac S, Steinberg A, McIntosh F. Physical and chemical effects of red cells in the shear-induced aggregation of human platelets. Biophys J. 1995;69:1584-1595.
24. Saniabadi AR, Lowe GD, Barbenel JC, Forbes CD. Effect of dipyridamole on spontaneous platelet aggregation in whole blood decreases with the time after venipuncture: evidence for the role of ADP. Thromb Haemost. 1987; 58:744-748.
25. Ohno M, Kishimoto T, Jidoi J, Tada M. Assessment of production of endothelium-derived relaxing factor (EDRF) by cultured human vascular endothelial cells based on its anti-aggregatory effect on human platelets. Hum Cell. 1994;7:68-71.
26. Houston DS, Robinson P, Gerrard JM. Inhibition of intravascular platelet aggregation by endothelium-derived relaxing factor: reversal by red blood cells. Blood. 1990;76:953-958.
27. Mehta JL, Chen LY, Kone BC, Mehta P, Turner P. Identification of constitutive and inducible forms of nitric oxide synthase in human platelets. J Lab Clin Med. 1995;125:370-377.
28. Sase K, Michel T. Expression of constitutive endothelial nitric oxide synthase in human blood platelets. Life Sci. 1995;57:2049-2055.
29. Sprague RS, Ellsworth ML, Stephenson AH, Lonigro AJ. ATP: the red blood cell link to NO and local control of the pulmonary circulation. Am J Plysiol. 1996;271:H2717-H2722.
30. Perutz MF. Molecular anatomy, physiology and pathology of hemoglobin. In: Stammatayanopoulos G, ed. Molecular Basis of Blood Diseases. Philadelphia, Pa; WB Saunders; 1987:127-178.
31. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 1994;368:850-853.
32. Garg UC, Hassid A. Nitric oxide decreases cytosolic free calcium in Balb/c 3T3 fibroblasts by a cyclic GMP-independent mechanism. J Biol Chem. 1991;266:9-12.
33. 2+ release and influx responses in PC 12-64 cells. Eur J Pharmacol. 1995;289:113-115.
34. 2+ uptake into platelet membrane vesicles. Biochem Biophys Res Commun. 1996;222:780-785.